Shares of Tivity Health Inc (NASDAQ:TVTY) have been assigned an average rating of “Buy” from the ten research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $45.43.

Several equities analysts recently commented on TVTY shares. Oppenheimer boosted their target price on Tivity Health from $47.00 to $50.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 1st. SunTrust Banks set a $50.00 target price on Tivity Health and gave the stock a “buy” rating in a research report on Friday, October 27th. Zacks Investment Research upgraded Tivity Health from a “hold” rating to a “buy” rating and set a $52.00 target price for the company in a research report on Tuesday, October 31st. ValuEngine cut Tivity Health from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. Finally, Chardan Capital restated a “neutral” rating and set a $44.00 target price (up from $40.00) on shares of Tivity Health in a research report on Friday, October 27th.

In other Tivity Health news, insider Mary Flipse sold 5,000 shares of Tivity Health stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $48.11, for a total transaction of $240,550.00. Following the completion of the sale, the insider now owns 45,167 shares of the company’s stock, valued at $2,172,984.37. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Conan Laughlin sold 115,087 shares of Tivity Health stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $33.87, for a total value of $3,897,996.69. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 875,892 shares of company stock valued at $31,815,642. 8.42% of the stock is owned by company insiders.

Hedge funds have recently modified their holdings of the business. Flinton Capital Management LLC lifted its stake in Tivity Health by 63.5% during the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after purchasing an additional 1,360 shares during the last quarter. Riverhead Capital Management LLC lifted its stake in Tivity Health by 69.7% during the second quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after purchasing an additional 1,464 shares during the last quarter. SG Americas Securities LLC bought a new stake in Tivity Health during the third quarter worth about $210,000. Crossmark Global Holdings Inc. bought a new stake in Tivity Health during the third quarter worth about $279,000. Finally, Piedmont Investment Advisors LLC bought a new stake in Tivity Health during the second quarter worth about $290,000.

Shares of Tivity Health (NASDAQ:TVTY) traded down $0.25 during midday trading on Monday, hitting $36.35. The stock had a trading volume of 368,616 shares, compared to its average volume of 481,325. The stock has a market capitalization of $1,430.00, a PE ratio of 23.30, a PEG ratio of 1.95 and a beta of 0.18. Tivity Health has a one year low of $20.60 and a one year high of $48.50. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.60.

Tivity Health (NASDAQ:TVTY) last announced its quarterly earnings results on Thursday, October 26th. The company reported $0.46 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.36 by $0.10. The company had revenue of $137.70 million during the quarter, compared to analysts’ expectations of $137.95 million. Tivity Health had a return on equity of 30.23% and a net margin of 11.45%. Tivity Health’s revenue for the quarter was up 10.2% on a year-over-year basis. analysts predict that Tivity Health will post 1.6 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Tivity Health Inc (TVTY) Receives $45.43 Consensus Price Target from Analysts” was posted by Marea Informative and is the property of of Marea Informative. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.mareainformativa.com/tivity-health-inc-tvty-receives-45-43-consensus-price-target-from-analysts-updated-updated-updated/124873/.

About Tivity Health

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.